Breaking News
July 21, 2018 - New discovery could save millions of lives from fatal fungal infections
July 21, 2018 - OBD presents latest data on the use of EpiSwitch™ in predicting patient response to immunotherapy and identifying lymphoma subtypes
July 21, 2018 - Childhood adversity increases susceptibility to addiction via immune response
July 21, 2018 - Scientists identify potential target for the treatment of binge eating
July 21, 2018 - Whole-brain LIPUS therapy improves cognitive dysfunction in mice simulating dementia, Alzheimer’s
July 21, 2018 - Digital media use raising risk of ADHD symptoms among the young
July 21, 2018 - Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints
July 21, 2018 - Restoring mitochondrial function to reverse aging-related skin wrinkles, hair loss in mice
July 21, 2018 - SP PennTech introduces RW-500 rotary vial washer for biotech, pharmaceutical applications
July 21, 2018 - Researchers to study molecular mechanisms behind susceptibility of males to autism
July 21, 2018 - Fourth Published Clinical Trial Confirms Long-Term Safety of Niagen Supplementation at High Doses and Shows Potential for Improvement in Liver Health
July 21, 2018 - Parents say intense gun violence in PG-13 movies appropriate for teens 15 and older
July 21, 2018 - FAU researchers find possible cause of Parkinson’s disease in the patients’ immune system
July 21, 2018 - Protective qualities of ‘good cholesterol’ reduce after menopause
July 21, 2018 - Researchers develop new way to uncover hidden breast cancer tumors
July 21, 2018 - FDA approves first drug for treatment of adult AML patients with specific genetic mutation
July 21, 2018 - Top AI companies join hands to discover novel drugs for DMD
July 21, 2018 - Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications
July 20, 2018 - Researchers design proteins that can self-assemble into complex structures
July 20, 2018 - AVITA Medical expands management team to support launch of RECELL device to treat burns
July 20, 2018 - FDA Approves Tibsovo (ivosidenib) for Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation
July 20, 2018 - Developmental screening and surveillance rates remain low, new study suggests
July 20, 2018 - TGen opens tissue donation portal to advance DIPG research
July 20, 2018 - Health impact of highly processed summertime staples
July 20, 2018 - Exergaming can improve health in overweight and obese children, study shows
July 20, 2018 - Postmenopausal factors may impact heart-protective qualities of ‘good cholesterol’
July 20, 2018 - MRI and blood test combination results in improved prostate cancer diagnosis
July 20, 2018 - Update Health Professional and Consumer on Recent Recalled Products
July 20, 2018 - Researchers trace Parkinson’s damage in the heart
July 20, 2018 - Wearable device designed to measure cortisol in sweat
July 20, 2018 - Scientists demonstrate a new regulation mechanism for skeletal muscles
July 20, 2018 - Exposure to mobile phone radiation may negatively impact memory performance in adolescents
July 20, 2018 - SUSU scientists find alternative method to treat post-traumatic stress disorder syndrome
July 20, 2018 - Gestational diabetes may increase offspring’s heart disease risk
July 20, 2018 - New vaccine could protect unborn babies from Zika virus
July 20, 2018 - Researchers find high mercury and methylmercury concentrations in traditional Tibetan medicine
July 20, 2018 - Brief Safety Plan Intervention in ER Can Cut Suicidal Behavior
July 20, 2018 - The Mount Sinai Hospital receives accreditation as geriatric emergency department
July 20, 2018 - Toward a better understanding of Parkinson’s disease
July 20, 2018 - Med school communications office wins four national awards | News Center
July 20, 2018 - Professional baseball players with faster hand-eye coordination may have better batting performance
July 20, 2018 - Study looks into mechanisms that control sleep and wakefulness
July 20, 2018 - Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments
July 20, 2018 - Research reveals long-term efficacy of drug used to treat common cause of kidney failure
July 20, 2018 - Timing of dinner associated with breast and prostate cancer risks
July 20, 2018 - Health Tip: Performing the Heimlich Maneuver
July 20, 2018 - Nearly all adolescents have eating, activity or weight-related issues
July 20, 2018 - Sage launches new web-based tool that helps explore curated genomic analyses of Alzheimer’s
July 20, 2018 - High-performance porous polymeric material for chromatography applications
July 20, 2018 - New molecule shows great promise for future treatment of many cancers
July 20, 2018 - New research project investigates alternative treatments for eye infections
July 20, 2018 - Immune T cells are built to react as fast as possible, shows study
July 20, 2018 - ZHX2 protein could offer a new treatment strategy for kidney cancer
July 20, 2018 - EKF’s Quo-Lab POC HbA1c analyzer meets international quality targets for diabetes testing
July 20, 2018 - Health burdens of very high risk drinking are potentially large, study reveals
July 20, 2018 - Using miniature drug-filled nanocarriers to target headaches and tumors
July 20, 2018 - Researchers uncover cause for progression of prostate cancer to incurable stage
July 20, 2018 - Studies highlight issues regarding black lung, opioid overdose, police violence and more
July 20, 2018 - AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia
July 20, 2018 - Researchers are one step closer to developing eye drops to treat age-related macular degeneration (AMD)
July 20, 2018 - Patients maintain muscle mass five years after surgically induced weight loss
July 20, 2018 - AMSBIO introduces new, powerful CRISPR/Cas9 gene editing kits
July 20, 2018 - PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides
July 20, 2018 - Analysis reveals disparities in cancer death rates among minority groups
July 20, 2018 - Dr Maddy Parsons receives Royal Microscopical Society Life Science Medal
July 20, 2018 - Study finds link between DNA methylation and non-alcoholic fatty liver disease
July 20, 2018 - Military personnel with head trauma and football players with suspected CTE show similar brain changes
July 20, 2018 - Vidac Pharma Announces Initiation of Phase 2b Clinical Trial of VDA-1102 Ointment in Patients with Actinic Keratosis
July 20, 2018 - KKR is buying Envision Healthcare in a nearly $10B deal
July 20, 2018 - Older people with broken bones face higher risk of death for up to 10 years
July 20, 2018 - A simple pill for meth addicts on the cards
July 20, 2018 - UA researchers to repurpose ketamine to reduce side effects in Parkinson’s patients
July 20, 2018 - Child psychiatrist available on call to help assess separated immigrant children
July 20, 2018 - High bitter-taste sensitivity linked to increased risk of cancer
July 20, 2018 - Falling temperatures may lead to rise in numbers of deaths from stroke
July 20, 2018 - Supplemental oxygen prevents rise in morning blood pressure in OSA patients
July 20, 2018 - High fruit and vegetable intake linked to reduced risk of breast cancer
July 20, 2018 - Careful patient selection may help achieve good outcomes for vaginal mesh surgery
July 20, 2018 - Researchers raise viability of cloned mice using somatic cell nuclear transfer method
July 20, 2018 - 3HP for Latent TB Infection Treatment | 2018 | Newsroom | NCHHSTP
DNA-level biomarker can are expecting general survival for uncommon mind tumors

DNA-level biomarker can are expecting general survival for uncommon mind tumors

image_pdfDownload PDFimage_print

MGMT promoter methylation standing—knowledge accumulated at a DNA-level—can lend a hand are expecting general survival for sufferers with a unprecedented type of mind most cancers referred to as anaplastic astrocytoma, in keeping with a brand new research from The Ohio State College Complete Most cancers Heart – Arthur G. James Most cancers Sanatorium and Richard J. Solove Analysis Institute (OSUCCC – James).

The objective of this learn about used to be to decide the choice of sufferers with sure MGMT promoter methylation standing and its importance as a way of predicting survival results for sufferers with anaplastic astrocytomas. Erica Bell, PhD, assistant professor of radiation oncology served as first writer of the learn about. Arnab Chakravarti, MD, chair of radiation oncology on the OSUCCC – James, used to be senior writer and major investigator.

MGMT is a famous DNA restore gene and identified biomarker in grade four glioblastoma mind tumors, on the other hand, knowledge on its prognostic worth in different grade 2 and grade three kinds of mind tumors has been unclear. MGMT promoter methylation used to be calculated the use of the MGMT-STP27 style on this learn about.

“The scientific neighborhood has suspected that MGMT standing may well be used as a biomarker for predicting general survival in those sufferers, however get entry to to a big set of well-controlled scientific knowledge and paired specimens to verify this used to be missing,” says Bell. “Our learn about represents the primary knowledge confirming that MGMT promoter methylation standing can be utilized as an unbiased biomarker for predicting general survival in grade three tumors.”

She notes that this data will lend a hand oncologists determine sufferers much less most probably to reply to remedy according to the biology in their tumors and design higher scientific trials.

Bell will provide the findings (Summary No. 2781) on Sept. 26, 2017, at the once a year assembly of the American Society for Radiation Oncology (ASTRO) in San Francisco, the place she may also obtain some of the 2017 “Very best of ASTRO” awards.

Find out about Design and Effects

For this learn about, researchers analyzed knowledge from a countrywide cooperative staff trial (RTOG 9813) that enrolled 196 high-risk sufferers with anaplastic astrocytoma. Sufferers had been randomized into certainly one of two remedy hands: radiation treatment plus nitrosourea or radiation treatment and temozolomide.

MGMT promoter methylation standing used to be calculated for 58 sufferers – 62 % of sufferers examined sure for the biomarker. Bell and co-workers then particularly analyzed MGMT promoter methylation in correlation with general and progression-free survival results. Sufferers who had the MGMT biomarker additionally had upper general survival when compared with sufferers whose tumors didn’t raise this biomarker. No vital distinction in progression-free survival used to be noticed, even supposing there used to be a pattern towards importance.

Bell says your next step is to broaden higher predictive biomarker fashions that incorporate all identified markers, now not simply MGMT.

“This may increasingly lend a hand us higher perceive which explicit sufferers don’t seem to be doing effectively on standard-of-care and sign up the ones sufferers to scientific trials that can give us the most productive probability of most cancers keep watch over,” she provides. “If we perceive which sufferers don’t seem to be doing effectively on usual of care, we will be able to in point of fact focal point on designing explicit scientific trials to lend a hand the ones sufferers reach higher general survival.”


Discover additional:
A brand new prognostic classification would possibly lend a hand scientific decision-making in glioblastoma

Equipped through:
Ohio State College Clinical Heart

Tagged with:

About author

Related Articles